Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus?

Bilgin S., Aktas G., Kahveci G., Tel A. B., Kurtkulagi Ö., Duman T. T.

Bratislava Medical Journal, vol.122, no.2, pp.116-119, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 122 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.4149/bll_2021_017
  • Journal Name: Bratislava Medical Journal
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Page Numbers: pp.116-119
  • Keywords: frailty, inflammation, mean platelet volume/lymphocyte ratio, type 2 diabetes mellitus
  • Çanakkale Onsekiz Mart University Affiliated: No


OBJECTIVES: Frailty is a common problem in patients with type 2 diabetes mellitus (T2DM). It is considered to be associated with inflammation. Novel markers derived from hemogram, such as neutrophil/lymphocyte ratio (NLR) and mean platelet volume/lymphocyte ratio (MPVLR), are proposed as inflammatory markers. In present study, we aimed to compare NLR and MPVLR levels of frail patients with T2DM to non-frail diabetic subjects. METHODS: Diabetic subjects were grouped in frail and non-frail groups according to the Edmonton Frail Scale. General characteristics and laboratory data of the frail and non-frail groups were compared. RESULTS: The MPVLR of the frail (3.9 [1.4–13.2] %) group was significantly higher than that of the non-frail (3.4 [1.5–6.9] %) group (p = 0.02). MPVLR was positively and significantly correlated with Edmonton Frail Scale score (r = 0.21, p = 0.03). A MPVLR level greater than 3.41 % has 71 % sensitivity and 51 % specify in predicting frailty. CONCLUSION: We suggest that elevated MPVLR could be a finding that marks frailty in diabetic subjects. Inexpensive and easy-to-assess nature of the MPVLR may be useful in predicting frailty in type 2 diabetic population (Tab. 2, Fig. 1, Ref. 32). Text in PDF